Canadian Partnership Against Cancer: Where has it been, and where is it going?

Canadian Partnership Against Cancer: Where has it been, and where is it going?

Originally Broadcasted:
Thursday, November 29th 2018

1:00pm – 2:00pm ET

The webinar provided an introduction to the Canadian Partnership Against Cancer (CPAC), assessed the results achieved to date by the current Canadian Strategy for Cancer Control and discussed what should be considered in a renewed cancer strategy.

In particular, the presentation covered the following topics:

  • An overview of CPAC and the current Canadian Strategy for Cancer Control (CSCC)
  • A review of the current consultation opportunity that is intended to inform the development of a new CSCC
  • Perspectives on results achieved to date by CPAC and the current CSCC
  • Thoughts about where CPAC needs to go and what gaps should be filled with a renewed cancer strategy The discussion was followed by an interactive question and answer session.

Moderator:
• Bill Dempster, co-founder of 3Sixty Public Affairs Inc., is an in-demand health and pharmaceutical policy expert who works with a range of clients to navigate complex political, policy, regulatory and reimbursement challenges in the Canadian life sciences field

Presenter/Discussants:
• Gerry Jeffcott is a senior associate at 3Sixty Public Affairs who has more than 25 years of health and pharmaceutical policy experience. He is a recognized expert in the Canadian reimbursement review and approval process for new medications and a regular commentator on relevant policy questions.
• Dr. Jo Kennelly, a Canadian health and policy expert, with executive experience in the cancer research field, in political life and in the emerging field of artificial intelligence. From advocate to minister’s office during the formation of CPAC, Jo has a unique perspective to offer on what the vision for CPAC was and where it is headed.
• Barry Stein is president and CEO of Colorectal Cancer Canada and a long-time patient advocate who is often called upon to offer his expertise and perspective on issues that matter to patients.

View the slide deck: